14-10_house_marker_thin
 

News:

Monoclonal Antibodies Lead Cancer Research

Date Posted:
2013-01-09

Rockland develops a number of conjugated and unconjugated monoclonal antibodies for cancer research, utilizing one of the most stringent quality control processes in the industry to ensure repeatable results. Trust your next project to Rockland. Compromise elsewhere.

 

View the Full Newsletter